MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients

References

• Bachtiar I, Santoso JM, Atmanegara B, Gani RA, Hasan I, Lesmana LA, Sulaiman A, Gu J, Tai S. (2009). Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma. Clin Chim Acta 399:97–101.
   PubMed Web of Science ®Google Scholar
• Bernard D, Martinez-Leal JF, Rizzo S, Martinez D, Hudson D, Visakorpi T, Peters G, Carnero A, Beach D, Gil J. (2005). CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. Oncogene 24:5543–5551.
   PubMed Web of Science ®Google Scholar
• Cheng J, Guo JM, Xiao BX, Miao Y, Jiang Z, Zhou H, Li QN. (2011). piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin Chim Acta 412:1621–1625.
   PubMed Web of Science ®Google Scholar
• di Mario F, Cavallaro LG. (2008). Non-invasive tests in gastric diseases. Dig Liver Dis 40:523–530.
   PubMedGoogle Scholar
• Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, Bentwich Z, Hod M, Goren Y, Chajut A. (2008). Serum microRNAs are promising novel biomarkers. Plos ONE 3:e3148.
   PubMed Web of Science ®Google Scholar
• Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y. (2009). Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 24:652–657.
   PubMed Web of Science ®Google Scholar
• Guo J, Xiao B, Zhang X, Jin Z, Chen J, Qin L, Mao X, Shen G, Chen H, Liu Z. (2004). Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers. J Mol Med 82:768–774.
   PubMed Web of Science ®Google Scholar
• Hao J, Zhang S, Zhou Y, Liu C, Hu X, Shao C. (2011). MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem Biophys Res Commun 406:552–557.
   PubMed Web of Science ®Google Scholar
• Hu H, Du L, Nagabayashi G, Seeger RC, Gatti RA. (2010). ATM is down-regulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci USA 107:1506–1511.
   PubMed Web of Science ®Google Scholar
• Ikeguchi M, Kaibara N. (2005). Detection of circulating cancer cells after a gastrectomy for gastric cancer. Surg Today 35:436–441.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Guo J, Xiao B, Miao Y, Huang R, Li D, Zhang Y. (2010). Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol 45:17–23.
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Ochiya T. (2010). Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 101:2087–2092.
   PubMed Web of Science ®Google Scholar
• Lurje G, Schiesser M, Claudius A, Schneider PM. (2010). Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications. J Oncol 2010:392652.
   PubMedGoogle Scholar
• Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou ES. (2008). Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 54:1696–1704.
   PubMed Web of Science ®Google Scholar
• Martínez-Arribas F, Agudo D, Pollán M, Gómez-Esquer F, Díaz-Gil G, Lucas R, Schneider J. (2006). Positive correlation between the expression of X-chromosome RBM genes (RBMX, RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer. J Cell Biochem 97:1275–1282.
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513–10518.
   PubMed Web of Science ®Google Scholar
• Miyazono F, Natsugoe S, Takao S, Tokuda K, Kijima F, Aridome K, Hokita S, Baba M, Eizuru Y, Aikou T. (2001). Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery. Ann Surg 233:189–194.
   PubMed Web of Science ®Google Scholar
• Nelson KM, Weiss GJ. (2008). MicroRNAs and cancer: past, present, and potential future. Mol Cancer Ther 7:3655–3660.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55:74–108.
   PubMed Web of Science ®Google Scholar
• Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, Taccioli C, Zanesi N, Alder H, Hagan JP, Munker R, Volinia S, Boccadoro M, Garzon R, Palumbo A, Aqeilan RI, Croce CM. (2008). MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci USA 105:12885–12890.
   PubMed Web of Science ®Google Scholar
• Rohatgi PR, Yao JC, Hess K, Schnirer I, Rashid A, Mansfield PF, Pisters PW, Ajani JA. (2006). Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival. Cancer 107:2576–2580.
   PubMed Web of Science ®Google Scholar
• Sobin L, Wittekind C. (1997). International Union against Cancer. In: Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumours. 5th ed. New York: John Wiley, pp:59–62.
   Google Scholar
• Solcia E, Klöppel G, Sobin L, Williams E. (2000). Endocrine tumours of the gastrointestinal tract. In: Solcia E, editor. Histological typing of endocrine tumours. Berlin: Springer, pp:61–68.
   Google Scholar
• Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y, Zhuang SM. (2009). MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 69:1135–1142.
   PubMed Web of Science ®Google Scholar
• Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T, Hijiya N, Matsuura K, Fujioka T, Seto M, Moriyama M. (2010). MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 70:2339–2349.
   PubMed Web of Science ®Google Scholar
• Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, Yoshida K, Sasaki H, Nomura S, Seto Y, Kaminishi M, Calin GA, Croce CM. (2010). Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11:136–146.
   PubMed Web of Science ®Google Scholar
• Wan HY, Guo LM, Liu T, Liu M, Li X, Tang H. (2010). Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer 9:16.
   PubMed Web of Science ®Google Scholar
• Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT, Xia YJ, Ye ZY, Tao HQ. (2010). MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 46:2295–2303.
   PubMed Web of Science ®Google Scholar
• Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K, Ren G, Su T, Pan Y, Feng B, Xue Z, Wang X, Fan D. (2010). MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun 392:340–345.
   PubMed Web of Science ®Google Scholar
• Xiao B, Guo J, Miao Y, Jiang Z, Huan R, Zhang Y, Li D, Zhong J. (2009). Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta 400:97–102.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhu W, Zhang J, Huo S, Zhou L, Gu Z, Zhang M. (2010). MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity. Biochem Biophys Res Commun 395:275–280.
   PubMed Web of Science ®Google Scholar
• Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, Jiang Z, Cheng J, Xiao BX. (2010). Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med 88:709–717.
   PubMed Web of Science ®Google Scholar
• Zhu LH, Liu T, Tang H, Tian RQ, Su C, Liu M, Li X. (2010a). MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor. Febs J 277:3726–3734.
   PubMed Web of Science ®Google Scholar
• Zhu YM, Zhong ZX, Liu ZM. (2010b). Relationship between let-7a and gastric mucosa cancerization and its significance. World J Gastroenterol 16:3325–3329.
   PubMed Web of Science ®Google Scholar
• Zweig MH, Campbell G. (1993). Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39:561–577.
   PubMed Web of Science ®Google Scholar